<DOC>
	<DOCNO>NCT00768677</DOCNO>
	<brief_summary>This study topiramate see whether topiramate decrease binge eat behavior among adolescent young adult . The investigator also check whether topiramate affect cognitive function .</brief_summary>
	<brief_title>Topiramate Binge Eating Disorder Among Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<mesh_term>Binge-Eating Disorder</mesh_term>
	<mesh_term>Bulimia</mesh_term>
	<mesh_term>Bulimia Nervosa</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Subjects ( age 12 23 ) include Met criterion bulimia nervosa eat disorder NOS bingeeating behavior DSMIVTR , Had weight &gt; = 100th % expect body weight age , Engaged binge eat least week 9 12 week prior study entry , Were judge clinician stable enough treated psychiatric condition outpatient ( i.e , acute suicidality , hallucination , unstable vital sign persistently abnormal laboratory result due eat disorder ) . Subjects whose psychotropic medication change within 4 week prior entry start psychotherapy within 3 month prior entry exclude . Subjects also exclude take carbonic anhydrase inhibitor , carbamazepine , phenytoin , phenobarbital , valproic acid , even primrose oil oral contraceptive . Other exclusion criterion : history substance use disorder within 6 month prior study , IQ &lt; = 70 , medical condition cause weight loss ( i.e. , hyperthyroidism , diabetes mellitus type 1 , malignancy ) contra indicate treatment topiramate ( nephrolithiasis glaucoma ) , history non response poor tolerance topiramate past history nonadherence medication treatment .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>23 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>binge eat behavior</keyword>
	<keyword>adolescent</keyword>
</DOC>